Product Reports Resources Pricing Login Book a demo

Phil

Biotech & Life Sciences · Scottsdale, United States · Founded 2015

End-to-end prescription management and delivery service connecting patients with local pharmacies MoreLess

Phil.us is a healthcare technology startup that aims to revolutionize the way patients access their medications. The company operates in the healthcare and pharmaceutical markets, serving both healthcare providers (HCPs) and patients. Its primary offering is the PhilRx platform, a digital tool designed to streamline the process of obtaining prescribed medications.

The platform's main features include a national dispense network, real-time HIPAA compliant data, and actionable insights. It simplifies the prior authorization process, ensuring that patients can start their therapy without delay. By negotiating formulary access, Phil.us guarantees that prescriptions are covered by insurance, reducing the financial burden on patients.

The company's business model is centered around improving patient adherence to medication regimens and increasing the number of prescriptions covered by insurance. This is achieved by removing barriers to medication access and providing a seamless experience for both patients and healthcare providers.

Phil.us also offers consulting services to help healthcare providers optimize their channel strategies and build effective telemedicine programs. These services aim to improve patient access and drive transformative brand outcomes.

In terms of revenue generation, Phil.us likely makes money through a combination of platform subscription fees from healthcare providers, consultation fees, and possibly a percentage from each prescription filled through their platform.

In conclusion, Phil.us is a promising startup that leverages technology to simplify medication access and improve patient outcomes in the healthcare sector.

Keywords: Healthcare Technology, Patient Access, Medication Adherence, Prescription Coverage, Prior Authorization, Telemedicine, Consulting Services, HIPAA Compliant Data, Pharmaceutical Market, National Dispense Network.

Talent graph

Phil's talent

Book a demo to see the people
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on Phil's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 9 investors entered at this stage
Series A 5 investors entered at this stage
Crosslink Capital
Silicon Valley Bank
Transmedia Capital
GreatPoint Ventures
Tarsadia Investments
Series B+ 2 investors entered at this stage
Warburg Pincus
K2 HealthVentures

Global footprint

Where Phil has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States93.2%
🇵🇭 Philippines1.9%
🇮🇳 India1.2%
🇨🇦 Canada0.6%
🇲🇽 Mexico0.6%
Top 5 of 9 shown

Market sentiment

What the market is saying about Phil

An AI-synthesized read of the highest-engagement posts about Phil on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Phil on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.